The Young Age And Plant-Based Diet Hypothesis For Low Sars-Cov-2 Infection And Covid-19 Pandemic In Sub-Saharan Africa by Losso, J N et al.
Louisiana State University 
LSU Digital Commons 
Faculty Publications School of Nutrition & Food Sciences 
6-24-2021 
The Young Age And Plant-Based Diet Hypothesis For Low Sars-
Cov-2 Infection And Covid-19 Pandemic In Sub-Saharan Africa 
J N. Losso 
jlosso@lsu.edu 
M N. Losso 
M Toc 
J N. Inungu 
J N. Losso 
Follow this and additional works at: https://digitalcommons.lsu.edu/nutrition_pubs 
Recommended Citation 
Losso, J. N., Losso, M. N., Toc, M., Inungu, J. N., & Losso, J. N. (2021). The Young Age And Plant-Based 
Diet Hypothesis For Low Sars-Cov-2 Infection And Covid-19 Pandemic In Sub-Saharan Africa. Plant Foods 
For Human Nutrition https://doi.org/10.1007/s11130-021-00907-6 
This Article is brought to you for free and open access by the School of Nutrition & Food Sciences at LSU Digital 
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital 
Commons. For more information, please contact ir@lsu.edu. 
Plant Foods for Human Nutrition (2021) 76:270–280
https://doi.org/10.1007/s11130-021-00907-6
REVIEW ARTICLE
The Young Age and Plant‑Based Diet Hypothesis for Low SARS‑CoV‑2 
Infection and COVID‑19 Pandemic in Sub‑Saharan Africa
Jack N. Losso1  · MerryJean N. Losso2  · Marco Toc3  · Joseph N. Inungu4  · John W. Finley1 
Accepted: 15 June 2021 
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021
Abstract
Since the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the coronavirus 
disease-19 (COVID-19), in December 2019, the infection has spread around the globe. Some of the risk factors include 
social distancing, mask wearing, hand washing with soap, obesity, diabetes, hypertension, asthma, cardiovascular disease, 
and dysbiosis. Evidence has shown the incidence of total infection and death rates to be lower in sub-Saharan Africa when 
compared with North Africa, Europe and North America and many other parts of the world. The higher the metabolic syn-
drome rate, the higher the risk of SARS-CoV-2 infection. Africa has a lower rate of metabolic syndrome risk than many other 
continents. This paradox has puzzled several in the biomedical and scientific communities. Published results of research have 
demonstrated the exciting correlation that the combination of young age of the population coupled with their native plant-
based diet has lowered their risk factors. The plant-based diet include whole grains (millet, sorghum), legumes (black-eye 
peas, dry beans, soybean), vegetables, potato, sweet potato, yams, squash, banana, pumpkin seeds, and moringa leaves, and 
lower consumption of meat. The plant-based diet results in a different gut microbiota than of most of the rest of the world. 
This has a significant impact on the survival rate of other populations. The “plant-based diet” results in lower rates of obesity, 
diabetes and dysbiosis, which could contribute to lower and less severe infections. However, these hypotheses need to be 
supported by more clinical and biostatistics data.
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Introduction
Since the initial December 2019 outbreak and spread of the 
severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) and COVID-19 worldwide pandemic, the incidence 
during the first wave of SARS-CoV-2 infection and COVID-
19 remained lower in sub-Saharan Africa than many parts of 
the world (Fig. 1, Table 1). In both waves, with the exception 
of South Africa, the incidence remained remarkably low in 
sub-Saharan African countries compared to Europe, North 
America, South America, and India. In most sub-Saharan 
African countries, the incidence of SARS-CoV-2 infection 
and COVID-19 is confined to major metropolitan areas like 
Lagos, Kinshasa, Abidjan, Nairobi, Addis Ababa, Dakar, 
Accra, or Bamako. However, despite the dense populations 
in Lagos (14,368,000), Kinshasa (14,340,000), Abidjan 
(5,203,000), Nairobi (4,735,000), Addis Ababa (4,794,000), 
or Dakar (3,140,000), SARS-CoV-2 infectivity is lower 
than Sao Paolo with a population of 22,000,000, New York 
with a population of 18,804,000, Rio with a population of 
13,458,075, London with a population of 9,304,000, or New 
Delhi with a population of 30,291,000 [https:// coron avirus. 
jhu. edu/ map. html] (Fig. 1 and Table 1). With the exception 
of South Africa, other sub-Saharan African countries have 
some of the most poorly equipped healthcare systems and 
testing infrastructure for the infection in the world. Public 
health experts and the media have tried to explain the puz-
zling low SARS-CoV-2 infection and COVID-19 pandemic 
in most sub-Saharan Africa during the first wave of the 
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pandemic [1–4] [https:// www. washi ngton post. com/ world/ 
africa/ africa- coron avirus- low- cases- deaths/ 2020/ 12/ 10/ 
e907a 1c2- 3899- 11eb- aad9- 89592 27280 c4_ story. html]. Oth-
ers predicted that the mortality and morbidity will be higher 
from SARS-CoV-2 in sub-Saharan Africa than other parts of 
the world because of influx of 2 million Chinese nationals 
now living and working in Africa [5]. This is in combina-
tion with the widespread of communicable diseases in the 
continent [5]. COVID-19-induced mortality in sub-Saharan 
Africa was less than 1% of the first global COVID-19-in-
duced mortality [https:// coron avirus. jhu. edu/ map. html]. By 
2021, the continent was estimated to have less than 5% of 
the world cases [6]. These observations are puzzling the sci-
entific community around the world. It has been suggested 
that the low rate of COVID-19 related symptoms and fatality 
in sub-Saharan Africa may be associated with a number of 
factors including host genetics, previous exposures to viral 
infections, lack of testing, misdiagnosis, relatively high tem-
peratures on the continent, and the young age distributions 
of the populations in the region [4, 7].
We hypothesize that the combination of younger age dis-
tribution, plant-based diet, and gut microbiota will attenu-
ate the infectivity in the region. South Africa appears to be 
an outlier, or the exception to the hypothesis and will be 
explained later in this review. To support this hypothesis, 
we evaluated current literature on (1) The mechanism of 
SARS-CoV-2 infection and potential dietary inhibitors, (2) 
The younger age distribution of the sub-Saharan African 
population compared to the Americas, Europe, and India as 
the major risk factor for SARS-CoV-2 infection and COVID-
19 onset, (3) Diet and gut microbiota in sub-Saharan Africa 
versus dysbiosis as a risk factor for SARS-CoV-2 infection 
Fig. 1  SARS-CoV-2 incidence 
or total cases (TC), COVID-19 
related total death (TD), and 
death per million population 
(DM) in sub-Saharan African 
countries
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and COVID-19 onset worldwide, and (4) The association of 
major risk factors and comorbidities for SARS-CoV-2 and 
COVID-19 recently observed in sub-Saharan Africa com-
pared to the rest of the world.
The Mechanism of SARS‑CoV‑2 Infection 
and Potential Dietary Inhibitors
SARS-CoV-2 infection occurs when SARS-CoV-2 laden-
droplets from an infected person are transmitted to another 
individual. SARS-CoV-2 uses serine proteases to prime the 
virus and allow the virus to attach to the receptor angio-
tensin converting enzyme-2 (ACE2). The ACE2 receptor 
is expressed at high levels in nasopharynx, alveolar type II 
cells in the lungs, as well as on myocardial cells, esophagus 
keratinocytes, intestinal (ileum and colon) epithelial cells, 
kidney, pancreas, bladder urothelial cells, nervous system, 
and skin epithelial cells. Inhibiting the binding of the virus 
to the cell receptor prevents development of the infection. 
If the virus is successful in attaching to the cell receptor 
after being primed/activated or after endocytosis the virus 
is able to penetrate the cell, replicate, resulting in the cas-
cade of events, cause COVID-19. Trypsin-like proteases 
are commonly found in the respiratory tract [8]. High levels 
of ACE2 receptors are found in the respiratory tract which 
combined with serine proteases facilitate priming and bind-
ing of SARS-CoV-2 to the tissues. The severity of COVID-
19 can be exacerbated by old age, obesity, diabetes, hyper-
tension, cardiovascular disease, kidney disease, asthma, 
allergies, compromised immune system, and dysbiosis. 
Individuals with these conditions have impaired endothelial 
cells, dysbiosis, pre-existing systemic low-grade inflamma-
tion, increased expression of SARS-CoV-2 entry receptors 
including ACE2 and CD147, and elevated levels of serum 
proteases. For example, transmembrane protease serine 2 
(TMPRSS2) that can catalyze SARS-CoV-2 activation [9]. 
Strategies to inhibit proteases that prime the SARS-CoV-2 
virus for entry into the host cells are targets for nonvac-
cine or antiviral treatment for COVID-19 until newly intro-
duced vaccines prove their efficacies [10]. These priming 
proteases may be inactivated by bioactive compounds found 
in foods that most sub-Saharan Africans consume. Below 
is the analysis of the association of SARS-CoV-2 infection 
and COVID-19 risk factors and infection incidence, disease 
onset, and mortality in sub-Saharan Africa.
The Age Distribution of the Sub‑Saharan Africa 
Population as Major Risk Factor for SARS‑CoV‑2 
Infection and COVID‑19
SARS-CoV-2 severely infects elderly people (age 55 years 
and older), and manifestations of the COVID-19 infec-
tion is often more severe in elderly population regardless 
of race. Immunosenescence or impaired immune response 
is observed in the elderly more than young people. Japan 
has an older population distribution compared to the rest 
of the world. Throughout the first wave of the COVID-19, 
Japan where masks have been extensively used, reported 
lower infection and death rate among its old population than 
similar old populations in Asian countries. The Japanese 
populations used face masks more extensively than other 
Asian countries and Western nations where masks were not 
used before the pandemic [11]. Twenty-three percent of the 
Italian population is 65 years old or higher and Italy has one 
of the highest COVID-19 infection rate since the spring of 
2020 [12]. Old age is a major risk factor for SARS-CoV-2 
infection and severe COVID-19 because dysbiosis and 
reduced microbiota diversity are frequent in old people and 
predisposes these populations to COVID-19 severity. Older 
people in general throughout the world are at higher risk of 
SARS-CoV-2 infection and COVID-19 than younger people. 
The population distribution in sub-Saharan Africa does not 
have as many elderly people as the countries in the rest of 
the world. The median age of the population in sub-Saharan 
Africa is estimated at 19.7 years [13]. The median age of 
the population in South Africa, Laos, Italy, Belgium, Brazil, 
and Canada, is 28, 24, 47, 41, 33, and 41 years, respec-
tively https:// www. index mundi. com/. As seen in Fig. 1 and 
Table 1, the death rate in the Democratic Republic of Congo, 
Uganda, Rwanda, or Burundi is much lower than in Italy, 
Brazil, or Mexico. Young people have stronger immune sys-
tem than older adults, may develop symptomatic or mild 
Table 1  SARS-CoV-2 incidence or total cases (TC), COVID-19 
related total death (TD), and deaths per million population (DM) in 
the fifteen most affected countries in the world
Total cases Total deaths Deaths 
per mil-
lion
Country (TC) (TD) (DM)
USA 33,862,398 603,408 1,814
India 26,289,290 295,525 212
Brazil 15,976,156 446,527 2,088
France 5,581,351 108,437 1,668
Turkey 5,169,951 45,840 538
Russia 4,983,845 117,739 806
UK 4,457,923 127,710 1,873
Italy 4,183,476 125,028 2,071
Germany 3,646,600 87,852 1,046
Spain 3,636,453 79,620 1,702
Argentina 3,482,512 73,391 1,611
Colombia 3,192,050 83,719 1,630
Poland 2,863,031 72,691 1,923
Iran 2,815,882 78,194 921
Mexico 2,392,744 221,256 1,700
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infection that may be undetected until resolved [13]. SARS-
CoV-2 infection in young adults is not associated with the 
loss of ACE anti-inflammatory and anti-oxidative activity. 
As a result, young patients do not present with acute respira-
tory distress syndrome (ARDS) as do old people.
Diet and Dysbiosis in Sub‑Saharan Africa vs 
Dysbiosis as a Major Risk Factor for SARS‑CoV‑2 
Infection and COVID‑19
In sub-Saharan Africa, the staple diet is rich in plant-based 
diets including whole grains (millet, sorghum), legumes 
(black-eye peas, dry beans, soybean), vegetables, potato, 
sweet potato, yams, squash, banana, pumpkin seeds, and 
moringa leaves, and lower consumption of meat [14]. The 
plant foods are excellent sources of protease inhibitors 
including the trypsin and trypsin-chymotrypsin inhibitors, 
that are bioavailable and can prevent SARS-CoV-2 from 
attaching to the host cells [15]. Some of these plant foods 
such as the squash are also excellent sources of protease 
inhibitors that can help prevent blood clotting, a death caus-
ing factor in COVID-19 [16]. Major bean (Phaseolus) con-
suming countries in the world include Rwanda, Uganda, 
Tanzania, Burundi, and Costa Rica. As of May 22, 2021, 
the corresponding populations, confirmed cases of COVID-
19, and COVID-19 related deaths were 12.3 million; 26,602; 
349 in Rwanda, 46.13 million; 43,370; 350 in Uganda, 
59.7million; 509; 21 in Tanzania, 11.9 million; 4,451; 6 
in Burundi, and 5.0 million; 299,219; 3,765 in Costa Rica, 
respectively [https:// coron avirus. jhu. edu/ map. html]. In 
Uganda, Rwanda, and Burundi, colored beans are eaten 
three times a day in almost every household. The health 
benefits of cooked beans cannot be overstated. The protease 
inhibitors found in dry beans are also present in soybean and 
soy products. Major soymilk consuming countries include 
Hong Kong, Singapore, Thailand, China, and Malaysia. As 
of May 22, 2021, Hong Kong with 14 million population 
had 11,830 confirmed COVID-19 cases, and 210 COVID-19 
related deaths. Singapore with 5.7 million people had 61,770 
confirmed cases and 32 deaths. Thailand with 69.8 million 
people had 126,118 confirmed cases, and 759 deaths. China 
with 1.43 billion people, had 90,954 confirmed cases and 
4,636 deaths. Malaysia with 32.5 million people, 498,796 
confirmed cases, and 2,149 deaths [https:// coron avirus. jhu. 
edu/ map. htm]. Major tofu consuming countries include 
China, Japan, South Korea, Vietnam, and Philippines. China 
with a populations, of 1.43 billion had 90,954 confirmed 
cases, and three deaths per million. Japan had 126.3 million; 
people, 704,159 confirmed cases and 96 deaths per million. 
South Korea had 51.7 million people, 135,344 confirmed 
cases and 38 deaths per million. Vietnam had 97.5 million, 
41 confirmed cases, and 0.4 deaths per million. The Phil-
ippines had 108,900 million people, 1,171,403 confirmed 
cases and 178 deaths per million [https:// www. world omete 
rs. info/ coron aviru s/? utm_ campa ign= insta gramc oach1]. 
Laos with a population of 7.3 million had 1,763 confirmed 
COVID-19 cases and 2 COVID-19 related death. Cambo-
dia has a population of 16.8 million, 24,157 cases, and 165 
COVID-19 related death. TMPRSS2 gene expression is 
reduced by the isoflavone genistein which is prevalent in soy 
products including soymilk, tofu, miso, and soy flour [17]. 
TMPRSS2 gene is more highly expressed in Caucasians than 
Asians or African men [18]. In summary, countries with 
high per capita consumption of dry beans or soy products 
have shown low infection and death rate.
Banana (Musa species) is a major staple in Uganda, 
Rwanda, and many other countries. Africans consume 21 kg 
of banana and plantain per capita while the world per capita 
is about 11.7 kg. In Uganda, the per capita for banana and 
plantain is 191 kg [https:// www. iita. org/]. As of November 
14, 2020, Uganda had 46.13 million people, 15,402 con-
firmed cases and 144 deaths. Rwanda had 12.3 million peo-
ple, 5,362 confirmed cases and 42 deaths. Burundi had 11.9 
million people, 624 confirmed cases and 1 death. Unripened 
or ripened bananas contain an inhibitor of trypsin, chymot-
rypsin, and papain, and a heat-stable inhibitor of ACE [19, 
20]. Banana is a whole-fruit which provides prebiotics and 
in vitro data show that banana powder can produce anti-
inflammatory postbiotics short chain fatty acids (SCFA) 
including acetate, propionate, and butyrate [21].
Sweet potato (Ipomoea batatas) is heavily consumed 
in Nigeria, Tanzania, Ethiopia, and Angola. As of May 22, 
2021, populations, confirmed cases, and deaths in these 
countries were respectively 207.5 million; 165,944; 2,067, 
58.73 million; 509; 21, 114.96 million; 268,520; 4,060, and 
32.86 million;31,909; 709 [https:// www. world omete rs. info/ 
coron aviru s/? utm_ campa ign= insta gramc oach1?].
Sporamin A and B are the major storage proteins in sweet 
potato and endowed with a defense role as a Kunitz trypsin 
inhibitor [22]. Sweet potato also contains anti-coagulants 
coumarins, scopoletin, aesculetin, and umbelliferone. Purple 
sweet potato is a good source of pelargonidin, an anticoagu-
lant phenolic compound [23].
Yam (Dioscorea) is mostly consumed in West, Central, 
and East Africa. Dioscorin is the major yam storage protein 
and is a low temperature stable inhibitor of trypsin [24]. 
Yam is a good source of dietary fiber for SCFA production 
in the gut [25]. The low infectivity and death incidence in 
African countries including Uganda, the Democratic Repub-
lic of Congo, and Ivory Coast may be explained in part by 
high consumption of combination of yams, beans, melon and 
pumpkin seeds, and sorghum. All these plant foods are very 
rich in trypsin inhibitors and when cooked at temperature 
below 100 ℃, these foods preserve the trypsin inhibitory 
activity.
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When minimally processed, the foods mentioned above 
can be good sources of bioactives including the Kunitz 
trypsin inhibitor, cystatin, and cathepsin inhibitors that can 
inhibit SARS-CoV-2 infection [15, 16]. The plant bioactives 
mentioned above can stand high temperature of 100 ℃ for 
5–10 min but are heat stable at lower temperatures. In Africa, 
most foods are boiled and not canned or retorted at 121 ℃. 
The bioactive proteins in the legumes are anti-inflammatory 
and health-enhancing [26]. Beans are excellent sources of all 
the proteases mentioned early. Colored beans are also good 
sources of pelargonidin known for its in vivo antithrombic 
and antiplatelet properties [27]. Polyphenols in colored Pha-
seolus beans inhibit DPP4, α-amylase, α-glucosidase, and 
reactive oxygen species making colored beans a good food 
for diabetics who are at risk of SARS-CoV-2 infection [28]. 
Plant protease inhibitors prevent obesity [29] and inhibit 
enzymes associated with chronic diseases invasion and pro-
liferation [30]. These plant-based foods are good sources of 
protease inhibitors and anticoagulants.
Dysbiosis is the imbalance in favor of maladaptive and 
pathogenic bacteria in the host gut microbiota. Dysbiosis 
is significantly associated with all the identified major risk 
factors for COVID-19 including old age, obesity, diabetes, 
hypertension, cardiovascular disease, and compromised 
immune system [31]. Dysbiosis contributes to the course of 
COVID-19 because 70 to 80% of the body immune system 
is in the gastrointestinal tract and the immunological health 
of the gut that is reflected by the gut microbiota influences 
lung health through gut-lung axis [32]. Dysbiosis results 
in uncontrolled intestinal inflammation, a compromised 
immune system which exacerbates COVID-19. Dysbiosis 
increases gut permeability and the leakage of pro-inflamma-
tory lipopolysaccharides and pro-inflammatory cytokines in 
the blood that can exacerbate the cytokine storm and organ 
failure. Short or long-term consumption of diet that consists 
of high-fat, high meat fat and proteins, high reducing sugars, 
and low plant-based proteins and fiber, rapidly and reproduc-
ibly alters the human gut microbiome, causes the disrup-
tion of gut microbiota homeostasis, and develops dysbiosis 
[33]. The distribution and dominance of microbiota in the 
diet are rapidly altered by changes in diet. Dysbiosis signifi-
cantly affects severe COVID-19 patients. Dysbiosis is cause 
and consequence of COVID-19. The GI tract is exposed to 
any pathogen or antigen that is introduced into the respira-
tory system suggesting that SARS-CoV-2 virus that enters 
through the nose can also move to the gastrointestinal tract 
[34]. Both the lung and gastrointestinal tract are major sites 
of ACE2 receptors. In the lungs, following attachment of 
SARS-CoV-2 to ACE2-rich cells and endocytosis, if viral 
clearance is impaired, the immune system progresses 
towards cytokine release and cytokine storm. Enterobacte-
riaceae, a family of pathogenic bacteria found in gut dys-
biosis were identified in the lungs from diseased COVID-19 
patients [35]. This suggests that cytokines released by these 
bacteria in the lungs are similarly released in the gut and 
the gut-lung axis exacerbates disease severity in individuals 
with gut dysbiosis and co-morbidities.
To support the plant-based diet and gut microbiota 
hypothesis of low SARS-CoV-2 infectivity in sub-Saharan 
Africa, recent findings on gut microbiota of sub-Saharan 
Africans may hold some explanation. De Filippo et  al. 
(2010) investigated and compared human intestinal and 
fecal microbiota from European children from urban area 
of Florence, Italy and age-matched children from a rural 
African village of Burkina Faso [36]. The children from 
rural Burkina Faso somehow represented the children in 
most rural settings in sub-Saharan Africa while the children 
from Florence represented those in most Western countries’ 
settings. By using high throughput 16 rDNA sequencing and 
other biochemical analyses, De Filippo et al. found high 
levels of Bacteroidetes and very low levels of Firmicutes 
and abundance of Prevotella and Xylanibacter bacteria and 
more anti-inflammatory short chain fatty acids in the gut of 
Burkina Faso children than the Italian children [36]. Gut 
microbiome composition of people living on plant-based 
diet in sub-Saharan Africa and profiled through 16SrRNA 
gene analysis using 454- pyrosequencing of stool analyses 
revealed a higher gut microbiota diversity dominated by 
Actinobacteria (Bifidobacterium); Bacteroidetes (Bacte-
roides–Prevotella); Firmicutes (C. histolyticum, Eubacte-
rium, Oscillibacter, Butyricicoccus and Sporobacter); Pro-
teobacteria (Succinivibrio, Shigella and Escherichia) and 
Spirochaetes (Treponema) and depleted in only Actinobacte-
ria (Bifidobacterium catenulatum), Firmicutes (Clostridium 
difficile and Akkermansia muciniphila [37, 38]. Meanwhile 
the gut microbiota of people in western countries showed 
abundance of Firmicutes (Blautia, Dorea, Roseburia, Fae-
calibacterium, Ruminococcus, Oscillospira, C. perfringens, 
C. difficile and S. aureus); Bacteroidetes (Bacteroides), Act-
inobacteria (B. adolescentis and B. catenulatum) and Ver-
rucomicrobia (A. muciniphila)[38]. The presence of a highly 
diverse microbiota in sub-Saharan African populations who 
consume plant-based diet was confirmed by Vipperla and 
O’Keefe who showed the prevalence of Prevotella in the gut 
microbiome of the Africans compared to Africa- American 
whose gut microbiota was dominated by Bacteroides [39].
Diet has a major effect on the composition of the gut 
microbiota. The diet in Burkina Faso and many other sub-
Saharan African countries is mostly plant-based using whole 
grain (millet, sorghum), legumes (black-eye peas, dry beans, 
soybean), vegetables, and little meat. The plant-based diet 
is rich in protease inhibitors, fiber, prebiotics, phenolic 
compounds, minerals, all of which improve gut health. The 
fiber, prebiotics, and phenolics are fermented in the colon 
to produce anti-inflammatory short chain fatty acids acetate, 
butyrate, and propionate, and urolithins. In Florence, the 
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children consume typical western diet associated with high 
consumption of animal protein and fat, refined starch, reduc-
ing sugars, and low in plant-based ingredients. In recent 
work, De Filippo et al. showed that when Africans move 
from rural areas to major cities and adopt the Western type 
of diet, the gut microbiota profile changes with progres-
sive reduction in anti-inflammatory short chain fatty acids 
such as butyrate and propionate [40]. The rate of dysbio-
sis and COVID-19 is higher in major sub-Saharan African 
urban areas than rural areas. SARS-CoV-2 infectivity and 
COVID-19 is high in African- Americans and low in sub-
Saharan Africans. The high infection and fatality rates in 
South Africa can in part be explained by the high levels of 
processed foods including sweets and animal products and 
less unprocessed plant-based diet consumed in the coun-
try unlike other sub-Saharan African countries [41]. As a 
result, obesity, diabetes, hypertension, and other noncom-
municable chronic degenerative diseases are higher in South 
Africa compared to the rest of the sub-Saharan Africa. The 
higher the metabolic syndrome rate, the higher the risk of 
SARS-CoV-2 infection and COVID-19 development. Reg-
ular consumption of properly processed plant-based diet 
will improve gut microbiota and attenuate SARS-CoV-2 
infection.
The Association of Major Risk Factors 
for SARS‑CoV‑2 Infection and COVID‑19 and Current 
field Results in Sub‑Saharan Africa
Social Distancing, Mask Wearing, and Hand Washings 
with Soap
Social distancing, quarantine, mask wearing, and frequent 
hand washings with soap are the best practices to reduce 
the spread of SARS-CoV-2 infection. When these protec-
tive measures fail, COVID-19 has an increased likelihood 
of onset and progression. Densely populated areas are risk 
factors for rapid and uncontrolled SARS-CoV-2 infection 
dissemination and COVID-19 onset and propagation. Lagos, 
Kinshasa, Abidjan, Nairobi, Abuja, or Dakar are densely 
populated, yet these cities have lower rate of infectivity than 
comparable cities across South America, Europe, North 
America, and Asia with similar or high/dense populations. 
The second wave of COVID-19 that started in November 
2020 has been reported to be associated with an increase in 
the rate of infection, yet the total infection and death rates 
in Africa are insignificant compared to total infection and 
death rates in Western Europe and North America (Fig. 1 
and Table 1). Comparisons of results during the first wave 
and the second wave show that Sub-Saharan Africa still has 
a low rate of SARS-CoV-2 infection and COVID-19 related 
death (Fig. 1 and Table 1). In most African major cities, 
people are not abiding to social distancing, quarantine, mask 
wearing, and frequent hand washings with soap because 
most people work in informal business and cannot sustain a 
day without work [42–45].
Obesity
Obesity is a major risk factor for severe SARS-CoV-2 infec-
tion and COVID-19. SARS-CoV-2 severely infects obese 
subjects more than lean individuals [46, 47]. Diet-induced 
metabolic alterations including obesity play a significant role 
in the incidence and severity of COVID-19[48–50]. Adipose 
tissue is a key endocrine organ that secretes a plethora of 
factors including adipokines, chemokines, and cytokines that 
profoundly impact metabolism and immune system. Acute 
inflammation from COVID-19 may amplify existing chronic 
inflammation secondary to obesity and lead to more severe 
disease and poorer outcomes [51]. Furthermore, metabolic 
changes associated with obesity such as insulin and leptin 
resistance negatively impact immune cell function. All these 
changes substantially influence the immune cell growth and 
proliferation and affect glucose metabolism and activation 
which ultimately results in impairment of host immune 
defense.
Although lung ACE2 is a major target for SARS-CoV-2 
infection, the higher expression of ACE2 gene expression 
in human visceral and subcutaneous adipose tissue than 
human lung makes obese individuals more vulnerable to 
the infection and disease than lean individuals [52]. Obese 
individuals have higher levels of interleukin-6 (IL-6), tumor 
necrosis factor-alpha (TNF-α), ACE2 on adipocytes, leptin, 
lower concentration of adiponectin, hyperactivated mecha-
nistic target of rapamycin (mTOR), natural killer cells polar-
ized to non-cytotoxic, all of which can increase the duration 
of SARS-CoV-2 shedding [47]. SARS-CoV-2 virion from 
obese individuals is higher than virion from old people than 
virion from individuals with cardiovascular disease than 
virion from individuals with lung disease than virion from 
individuals with diabetes than virion from individuals with 
hypertension than virion from smokers than virion from 
healthy individuals and the size of virion is associated with 
the odds of developing severe viral infection [53]. The BMI 
of severe COVID-19 patients median have been reported to 
be higher than the BMI of non-severe patients. Obese indi-
viduals are prone to excessive oxidative stress, diminished 
airway flow, and severe obese individuals are at risk of heart 
failure. Like the rest of the world, Sub-Saharan Africa is 
experiencing a rise in obesity because of increased urbaniza-
tion, westernization of lifestyle, decreased physical activity, 
increased sedentary lifestyle, and less consumption of fruits 
and vegetables but high overindulgence on energy-dense 
processed foods in urban areas [54]. Descriptive data analy-
sis of obesity prevalence by country showed higher adult 
obesity values in the Americas and Europe and lower values 
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in Asia and Africa [55]. Several studies have observed the 
higher incidence of adult overweight and obesity in urban 
areas compared to rural regions of sub-Saharan Africa. [56]. 
While the incidence of obesity is increasing in major Afri-
can cities, it is low (< 5% of its population) compared to 
the West or South East Asia. https:// world popul ation review. 
com/ count ry- ranki ngs/ most- obese- count ries. With 1.038 bil-
lion people, sub-Saharan African has less than 30 million 
obese compared to Brazil which has more than 70 million 
obese people (33.5% of its population of more than 211 mil-
lion people). The prevalence of obesity in US was 42.7% 
in 2017–2018 [www. cdc. gov] and about 28% in Canada in 
2017 [https:// obesi tycan ada. ca/ guide lines/ epide miolo gy. 
Accessed 1/26/2021]. India alone with 1.353 billion people 
has 5 million obese. China with 1,393 billion people has 
about 70 million obese. SARS-CoV-2 infectivity spreading, 
and fatality is higher in Europe, North America, Brazil, UK, 
and Mexico where obesity with median BMI > 25 kg/m2 is 
also highly prevalent [47]. Obesity is a major risk factor for 
severe SARS-CoV-2 infection and COVID-19 even in young 
people. SARS-CoV-2 infectivity and COVID-19 incidence 
are higher in major African cities than in the rural areas in 
part because processed diet-induced obesity is prevalent in 
urban areas than rural [41]. Mean BMI in Africa is < 22 kg/
m2 [57]. The level of physical activity is higher in rural 
sub-Saharan African villages than in metropolitan African 
cities [58]. The interpersonal contacts are higher between 
dwellers of major sub-Saharan African cities and popula-
tions from countries with high infection rates than between 
rural African populations and populations external to the 
African region.
Diabetes
Diabetes is a major comorbidity risk factor for severe SARS-
CoV-2 infection. Diabetic patients, especially those with 
uncontrolled blood glucose, are at greater risk for devel-
oping severe COVID-19 disease than healthy individuals. 
About 98% of adults with type 2 diabetes carry at least one 
or two comorbidities including hypertension, overweight/
obesity, chronic kidney disease, or cardiovascular disease 
[59]. Each of these comorbidities is by itself a risk factor 
for severe COVID-19 outcome. The hyperglycemic environ-
ment of diabetic blood increases glucose secretion within 
the airway and promotes immune dysfunction by damag-
ing neutrophil function, repressing the protective antioxi-
dant/anti-inflammatory system and the humoral immunity, 
causing micro- and macro-angiopathies, neuropathy, and 
reducing the antibacterial activity of urine. Diabetes trig-
gers a pro-inflammatory cytokine environment in the body 
associated with high levels of IL-6 and C-reactive protein. 
ACE2 is expressed at lower levels in the pancreas, kidneys, 
vascular system, and lungs of individuals with diabetes. 
Consequently, these individuals have reduced anti-inflam-
matory and anti-oxidative capabilities. All these alterations 
including compromised glycemic status, innate immune sys-
tem, and humoral immunity inhibit resistance to any infec-
tion including SARS-CoV-2 infection. The interaction of 
SARS-CoV-2 with pancreatic ACE2 may lead to β-cell dys-
function-induced hyperglycemic state causing acute diabetes 
state [60]. Ex-vivo study has shown that lung monocytes and 
macrophages of COVID-19 infected people are highly gly-
colytic, facilitate SARS-CoV-2 replication and cytokine pro-
duction. These changes initiate mitochondrial reactive oxy-
gen species production and stabilizing the hypoxia-inducible 
factor-1 α (HIF-1α) [61]. HIF-1α-induced metabolic altera-
tions in COVID-19 infected monocyte increase glycolysis 
and cytokine such as IL-1β production which drives T cell 
dysfunction and lung epithelial cell death. Increased circu-
lating glucose levels in CoV-2 infected monocyte can pro-
mote T cell dysfunction and lung epithelial cell apoptosis 
in a mitochondrial-ROS/HIF-1α-dependent manner [61]. 
In sub-Saharan Africa, the prevalence of type 2 diabetes in 
adults older than 55 years is about 13% and higher in urban 
than rural settings [62]. While individuals with diabetes 
are at increased risk arising from severe complications of 
SARS-CoV-2, there are less people with diabetes in Africa 
(an estimated 15.5 million out of 1.2 billion people) [63] 
than China (about 110 million patients out of 1.4 billion 
people) than India (an estimated 120 million people out of 
1.35 billion people) [64]. There are about 34 million people 
with diabetes in the US (about 10% of the population) [www. 
cdc. gov].
Hypertension
SARS-CoV-2 severely infects individuals with high blood 
pressure who display more than three-fold higher mortality 
and short-term mortality rate than normotensive individuals 
[65]. One potential mechanism of the contribution of hyper-
tension to severe COVID-19 is as follows. Plasminogen acti-
vator inhibitor-1 (PAI-1) levels are high in hypertension, 
old age, obesity, diabetes, and cardiovascular disease [66]. 
Severe COVID-19 develops hypoxia in the lungs. Hypoxia, 
through hypoxia-inducible factor-1 alpha (HIF-1α), stimu-
lates the production of PAI-1 in the lung [67]. Injury in the 
lungs of SARS-CoV-2 infected individuals leads to over-
production of hyaluronan and the latter also leads to pro-
duction of more PAI-1. Excessive PAI-1 binds to toll-like 
receptor 4 (TLR4) on macrophages, activates NF-κB which 
in turn induces the secretion of pro-inflammatory cytokines 
and chemokines in the lungs of severely ill patients with 
COVID-19. The up-regulation of PAI-1 leads to coagulopa-
thy characterized by intravascular thrombi [66]. The inci-
dence of sequelae of uncontrolled hypertension, specifically 
stroke and hypertension heart disease, is greater in Africa 
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than in many other parts of the world [68]. Hypertension 
afflicts about 46% of African adults aged 25 years and older 
[69]. There were 130 million African adults with hyperten-
sion in 2010 and the number is expected to increase to 220 
million by 2030 [69]. Awareness for hypertension is < 30%, 
treatment < 20%, and control rate < 10% [69]. However, 
the rate of SARS-CoV-2 infection is low in this part of the 
world. SARS-CoV-2 infectivity and COVID-19 is low in 
Africa. In sub-Saharan Africa, COVID-19 severity and 
fatality have shown discordant association with the disease 
comorbidity risk factors including hypertension, diabetes, 
and cardiovascular disease whereas in North African coun-
tries such as Algeria and Egypt a positive association was 
established between the disease severity and the risk factors 
[70]. COVID-19 outcome in Africa may be associated with 
the modulation of the renin–angiotensin–aldosterone system 
(RAAS) axis, which controls ACE/ACE2 balance, in the 
region [70].
Cardiovascular
Pre-existing cardiovascular disease such as coronary heart 
disease is a comorbidity factor for severe COVID-19 out-
comes. Globally speaking, cardiovascular disease dispro-
portionately affects sub-Saharan Africans where the affected 
are younger, female, hypertensive and are chronic smokers 
[68]. Despite high prevalence of hypertension and smok-
ing, SARS-CoV-2 infectivity and COVID-19 pandemic are 
low in the observed sub-Saharan African population. SARS-
CoV-2 infected patients with pre-existing cardiovascular dis-
ease are a greater cardiac failure than healthy individuals. 
There is a discordant pattern between the high prevalence of 
cardiovascular disease in sub-Sahara Africa and COVID-19 
severity and fatality [70].
Asthma in Sub‑Saharan Africa, SARS‑CoV‑2 Infection, 
and COVID‑19
Asthma is a risk factor for severe COVID-19 outcomes 
because asthmatics have deficient and delayed innate anti-
viral immune responses, and deficient and delayed lung cell 
interferon (IFN)‐α, IFN‐β, and IFN‐λ responses. SARS-
CoV-2 infection, like asthma, induces an attenuated IFN-I 
and INF-III signature and therefore SARS-CoV-2 and the 
resultant unopposed TH2 response exacerbates asthma 
[71]. Asthma has an estimated high prevalence of 12% in 
Africa [72]. Gut and lung dysbiosis are increasingly being 
associated with the incidence and severity of asthma [73]. 
In sub-Saharan Africa, gut dysbiosis is more prevalent in 
urban populations than rural ones. Similarly, asthma is 
more prevalent in urban populations than rural populations. 
A positive dose–response association between consump-
tion of fast foods three times or more in a week and asthma 
and allergies was found in urban areas of South Africa [74]. 
However, SARS-CoV-2 infectivity and COVID-19 are low 
in sub-Saharan Africa.
Conclusion
The correlation between the administration of the Bacille 
Calmette-Guérin (BCG) vaccine for tuberculosis and SARS-
CoV-2 infection and COVID-19 severity is striking [75]. 
It is not known whether exposure to BCG directly reduces 
SARS-CoV-2 infectivity or not, however several stud-
ies have shown relatively low SARS-CoV-2 infections in 
countries that implemented universal BCG vaccinations 
(including most sub-Saharan African countries, Japan, India, 
Afghanistan, Nepal, Bhutan, Bangladesh, Israel, and others) 
and high infections and mortalities in countries that have 
BCG immunization programs only for high-risk communi-
ties (USA, Canada, Italy, Spain, France, Germany, South 
Korea, Iran) [75]. However, American Indians, Alaskan 
natives, India, and Brazil’s BCG adherence does not seem 
to support the high SARS-CoV-2 infection and COVID-19 
mortality rate in these communities [75] [https:// www. world 
omete rs. info/ coron avirus/]. The prevalence of co-morbidi-
ties including diabetes and obesity in American Indians and 
Alaskan natives, diabetes in India, and obesity and diabetes 
in Brazil may explain the inefficacy of the BCG vaccine 
against these SARS-CoV-2 co-morbidities in these popu-
lations. Others have suggested that the nonspecific effect 
of the BCG vaccine over the immune system is unknown 
and needs to be tested appropriately [76]. COVID-19 can 
have serious post-disease side effects, which underline 
the benefits of preventive efforts over aggressive manage-
ment of the disease. Plant-based diet rich in inhibitors of 
SARS-CoV-2 infection may reduce the severity of infec-
tion and be a bridge to an effective vaccine. The strength of 
the hypothesis put herein includes the association between 
plant-based diet and reduced dysbiosis and the young age in 
the region, which together can help reduce infectivity in the 
event of contact with populations from regions with high 
infection rate. However, this hypothesis needs to be reported 
and then tested through well designed clinical studies and 
biochemical analyses to determine the potential correlation 
between youth and plant protease inhibitor-rich diet and the 
low SARS-CoV-2 infectivity and COVID-19 in sub-Saharan 
Africa. The landscape of COVID-19 is evolving very fast to 
the point that current efforts are merely and mostly invested 
into managing clinical outcomes. Later, during the post-
COVID-19 vaccine era, there will be a need in due course, 
for reflection for consolidating food science and nutrition 
potential contributions to the prevention and management 
of SARS-CoV-2 infection and COVID-19. The COVID-19 
pandemic is a public health concern that affects and requires 
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the contribution of food science and nutrition to this medical 
problem. The landscape of the disease risk factors under-
scores the importance of bringing food scientists and nutri-
tionists onboard with the medical community to find effec-
tive solutions for preventing and managing the pandemic.
This hypothesis has limitations. The data analyzed were 
from publicly available literature database including Pub-
Med. The hypothesis assumes homogenous rural and urban 
populations and behavior across the sub-Saharan African 
region throughout the pandemic state although each country 
has socio-economic characteristics which may not equally 
overlap with other countries in the region. The discovery 
of new variants of the virus in the United Kingdom, South 
Africa, and Brazil which has already been detected in Can-
ada, the US, and South Korea may bring about different 
response from the populations that have been resistant to 
the first wave of the virus. However, continuous use of social 
distancing, hand washings with soap, face masks, and plant-
based rich diet will help prevent and reduce the spread of 
the infection.
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